✦ LIBER ✦

The Impact of Chronic Obstructive Pulmonary Disease in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction: An Analysis of the EVEREST Trial

✍ Scribed by Robert J. Mentz; Philip H. Schmidt; Mary J. Kwasny; Andrew P. Ambrosy; Christopher M. O'Connor; Marvin A. Konstam; Faiez Zannad; Aldo P. Maggioni; Karl Swedberg; Mihai Gheorghiade

Book ID: 116341485
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 351 KB
Volume: 18
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2012.04.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Value of Monocyte Count in Pa

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

✍ Stephen J. Greene; Matthew E. Harinstein; Muthiah Vaduganathan; Haris Subačius; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 368 KB

The burden of chronic obstructive pulmon

The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure

✍ Mitja Lainscak; Lea Majc Hodoscek; Hans-Dirk Düngen; Mathias Rauchhaus; Wolfram 📂 Article 📅 2009 🏛 Springer Vienna 🌐 English ⚖ 218 KB

Gender Does Not Affect Postdischarge Out

Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)

✍ Ami N. Shah; Robert J. Mentz; Mihai Gheorghiade; Mary J. Kwasny; Angela J. Fough 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Atrial fibrillation or flutter on initia

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

✍ Robert J. Mentz; Matthew J. Chung; Mihai Gheorghiade; Peter S. Pang; Mary J. Kwa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 511 KB

Clinical, Neurohormonal, and Inflammator

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

✍ Lidia Staszewsky; Maylene Wong; Serge Masson; Simona Barlera; Elisa Carretta; Al 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 271 KB

THE ASSOCIATION OF BETA-BLOCKER USE AND

THE ASSOCIATION OF BETA-BLOCKER USE AND SELECTIVITY WITH OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM THE ORGANIZED PROGRAM TO INITIATE LIFE-SAVING TREATMENT IN HOSPITALIZED PATIENTS WITH HEART FAILURE

✍ Robert J. Mentz; Daniel Wojdyla; Mona Fiuzat; Karen Chiswell; Tariq Ahmad; Gregg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 92 KB